Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0577
Source ID: NCT01932268
Associated Drug: Rifampicin
Title: A Pilot Study for Pharmacokinetic Parameter of Colchicine in Patient Taking Rifampin
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Chronic Kidney Disease|Tuberculosis
Interventions: DRUG: Rifampicin
Outcome Measures: Primary: a change of the colchicine concentration from baseline at 1,2,4,8,24 hours after Rifampicin administration, the colchicine concentration of baseline(C0) and at 1(C1),2(C2),4(C4),8(C8),24(C24) hours after Rifampicin administration |
Sponsor/Collaborators: Sponsor: Seoul National University Hospital
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 2
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Start Date: 2011-01
Completion Date: 2011-12
Results First Posted:
Last Update Posted: 2013-08-30
Locations:
URL: https://clinicaltrials.gov/show/NCT01932268